2026 Conference Program

Last updated: April 30, 2026

Opening activities and plenary sessions will be livestreamed for virtual attendees. The workshop program is primarily offered for in-person attendees.

All times shown are in Eastern Time (UTC -5).

The 2026 Program is proudly co-hosted by the CBITN

The IBTN’s Canadian sister association, the Canadian Behavioural Interventions and Trials Network

Thursday, May 7 – Conference Opening Activities

Time Session Pavilion Sherbrooke
12h30 CBITN networking lunch and roundtable discussionexclusively for CBITN members  Salle polyvalente
16h00 Participant registration Foyer
16h50 Welcome and Opening Remarks

IBTN co-chairs Simon Bacon, PhD (Canada) and Kim Lavoie, PhD (Canada)

Room SH-2800
17h00 Opening plenary Room SH-2800
Keynote by Paschal Sheeran, PhD (USA) – Individuals, Systems, and Health Behaviour Change
18h00 IBTN Investigator Award ceremony and presentations Room SH-2800
19h00 Cocktail reception and poster session Upper Level

Friday, May 8 – Scientific Plenary Day

Time Session Speakers / Location (Pavillon Sherbrooke)
8h00 Participant arrival and registration, and light on-site breakfast Foyer
8h15 Welcome and Introduction by IBTN Co-Chairs Room SH-2800
8h30 Early Morning Plenary Sessions Room SH-2800
The Role of Behavioural Science in Addressing Major Public Health Challenges Chair: Iveta Nagyova, PhD (Slovakia)
Co-chair: Marilyn Ahun, PhD (Canada)
8h30

Building capability for behavioural research across sectors: from emergency response to health information integrity (provisional title)

Linda Bauld, PhD (UK)
8h50

Behavioural science for Public Health in Europe

Jet Sanders, PhD (The Netherlands)
9h10 Discussion Led by Paschal Sheeran, PhD (USA)
10h00 Break Upper Level
10h30 Mid-Morning Plenary Sessions Room SH-2800
Leveraging Behavioural Science to Design More Effective AI-Driven Lifestyle Interventions Chair: Nadia Griva, PhD (Singapore)

Co-chair: Jen Brown, PhD (UK)

10h30

When Behavioural Science Drives the Algorithm

Amy Bucher, PhD (USA)
10h50 Personalization That Works: Leveraging Behavioural Science to Design Adaptive AI Interventions (provisional title) Oladapo Oyebode, PhD (Canada)
11h10 Discussion Led by Simon Bacon, PhD (Canada)
12h00 Lunch Upper Level
13h00 Early Afternoon Plenary Sessions Room SH-2800
The Role Of Behaviour Change in the Era of Weight Loss Drugs (GLP-1s) Chair: Mylène Aubertin-Leheudre, PhD (Canada)

Co-Chair: Sean Locke, PhD (Canada)

13h00 The Role Of Behaviour Change in the Era of Weight Loss Drugs (GLP-1s): Risks and Opportunities Michael Vallis, PhD (Canada)
13h20 Behaviour in the Era of Obesity Management Medications: Challenges and Opportunities John Jakicic, PhD (USA)
13h40 Discussion Led by Susan Czajkowski, PhD (USA)
14h30 Mid-Afternoon Plenary Sessions Room SH-2800
Excellence in Canadian Behavioural Health Research: The Power of Networks Chair: Kim Lavoie, PhD (Canada)

Co-chair: Vincent Gosselin Boucher, PhD (Canada)

The Power of Networks: IBTN and CBITN Simon Bacon, PhD (Canada)

Building the Canadian Network for Psychedelic-Assisted Cancer Therapy (CAN-PACT) from the Ground Up (provisional title)

Linda Carlson, PhD (Canada)

Family Physical Activity Interventions

Ryan Rhodes, PhD (Canada)
Networks Expand Ideas: The case for determining the mechanisms of cognitive reframing Sean Locke, PhD (Canada)

From local links to global collaborations: Leveraging professional connections as a behavioural science trainee

Alysha Deslippe, PhD (Canada)
Designing Behavioural Infrastructure: What the Adaptive Mentoring Networks Teach Us About Sustainable Networks Arun Radhakrishnan, MD (Canada)
15h30 Discussion Led by Kim Lavoie, PhD (Canada)
16h00 Break Upper Level
16h30 Late Afternoon Plenary Sessions Room SH-2800
From Efficacy to Impact: Addressing Gaps in Implementation and Scaling of Behavioural Interventions for Chronic Disease Prevention Chair: Marta Marques, PhD (Portugal)

Co-chair: Grégory Ninot, PhD (France)

16h30 Lessons Learned Implementing Remote Hypertension Monitoring in Primary Care Ian Kronish, MD (USA)
16h50 Implementation laboratories in the public health system (provisional title) Falko Sniehotta, PhD (Germany)
17h10 Discussion Led by Ken Freedland, PhD (USA)
18h00 Poster award ceremony and closing remarks IBTN Co-Chairs

Saturday, May 9 – Workshop Day

Time Session Location/Speakers
8h00 Light on-site breakfast Location to be announced on site
9h00 Morning Workshops – with 15-minute health break Rooms to be announced on site
WKSP1 Designing interventions using the Behaviour Change Wheel and COM-B Model – View description Marta Marques, PhD (Portugal)
WKSP2

Co-creation of behavioural interventions: Methods for integrating stakeholders to optimize implementation – View description

Molly Byrne, PhD (Ireland)
WKSP3 Attacking the roots of mis/disinformation: How health misinformation spreads and how we can apply lessons from behavioural science to combat it – View description Emily Vraga, PhD (USA)
12h30 Lunch Location to be announced on site
13h30 Afternoon Workshops – with 15-minutes health break Rooms to be announced on site
WKSP4 Moving From Preliminary Studies to Randomized Trials: Guidance from the ORBIT Model – View description Lynda Powell, PhD (USA), Susan Czajkowski, PhD (USA) and Ken Freedland, PhD (USA)
WKSP5 Bringing Evidence to the People: Strategies to Enable the Uptake of Evidence-Based Public Health Interventions for Population Health and Equity – View description Falko Sniehotta, PhD (Germany)
WKSP6 Strategies for rapid design and prototype testing of digital behavioural interventions – View description Sam Liu, PhD (Canada)
16h30 End of Workshops
19h00 Closing dinner
Les Soeurs Grises – Old Montreal (32 McGill Street)

WORKSHOP 1: Designing interventions using the Behaviour Change Wheel and COM-B Model

Morning Session (9h00 to 12h00) – Marta Marques, PhD (Portugal)

The Behaviour Change Wheel (BCW) is a systematic, evidence-based framework for designing behaviour change interventions. At its centre is the integrative COM-B model of human behaivour, which provides a way to systematically identify and categorize barriers and enablers to change. This workshop introduces you to applying the BCW and COM-B model to intervention development, with emphasis on the Behaviour Change Technique Ontology—a comprehensive classifation for standardizing and specifying evidence-based teqhniques.  Case examples will illustrate each step, with opportunity to discuss how to apply these on your own.

Learning Outcomes

  1. Explain the Behaviour Change Wheel framework and its key components to understand the systematic approach to designing behavior change interventions
  2. Use the COM-B model to diagnose what needs to change—identifying the capabilities, opportunities and motivations that are barriers or enablers to behavior change
  3. Select and specify evidence-based behaviour change techniques using the Behaviour Change Technique Ontology to design targeted, effective interventions

WORKSHOP 2: Co-creation of behavioural interventions: Methods for integrating stakeholders to optimize implementation

Morning Session (9h00 to 12h00) – Molly Byrne, PhD (Ireland)

In this workshop, you will learn about approaches to engage key stakeholders in co-designing research to develop, evaluate and implement effective behaviour change interventions. You will apply your learning to your own research area and develop ideas and strategies in discussion with other workshop participants.

This workshop will introduce key themes, frameworks and references relevant to stakeholder engagement and coproduction. Workshop participants will have an opportunity to learn about the application of stakeholder engagement across all stages of the research development pipeline: from conceiving the initial research question, through intervention development, to selecting which outcomes matter, and evaluating and implementing interventions in the ‘real world’. The workshop will provide hands-on experience and guidance in using stakeholder engagement and coproduction in participants’ own research.

WORKSHOP 3: Attacking the roots of mis/disinformation: How health misinformation spreads and how we can apply lessons from behavioural science to combat it

Morning Session (9h00 to 12h00) – Emily Vraga, PhD (USA)

*Participants are encouraged to bring a laptop or a tablet to this workshop.

Leading health organizations and government agencies have recognized the threat that mis- and disinformation can create for public health and democratic societies. A number of complementary forces contribute to the spread of misinformation, including how individuals process information, institutional constraints in how information is produced, and the affordances by which individuals encounter diverse information, particularly in digital media environments. With this framework, we turn our attention to identifying the critical intervention points where efforts to disrupt misinformation supply, distribution, uptake, and demand are most likely to be effective (National Academies of Sciences, Engineering, and Medicine, 2025). We’ll consider how inoculation theory may inform intervention efforts and pay special attention to the rewards and risks of attempting to mitigate misinformation in online spaces.

Learning Objectives:

  • Understand how information processing contributes to misinformation belief
  • Recognize contextual affordances that encourage the spread of mis/disinformation
  • Identify critical intervention points to mitigate misinformation spread

WORKSHOP 4: Moving From Preliminary Studies to Randomized Trials: Guidance from the ORBIT Model

Afternoon Session (13h30 to 16h30) – Lynda Powell, PhD (USA), Susan Czajkowski, PhD (USA) and Ken Freeland, PhD (USA)

ORBIT is a widely used translational research model that is designed to guide the development, refinement, and testing of health-related behavioral and psychosocial interventions. This workshop will focus on transitioning from early phases of the model to studies demonstrating Proof-of-Concept (Phase IIa), Feasibility (Phase IIb), and Efficacy (Phase IIc and Phase III Efficacy trials). We will first provide an overview of the ORBIT model, highlighting its key objectives, features and methods. Speakers will then address topics such as how to identify and use specific milestones or “Go-No Go criteria” to move from one phase to another; the use of hybrid phases (e.g., combining Proof-of-Concept and Feasibility studies); and the distinction between Phase II and Phase III Efficacy trials. Examples of studies illustrating these points will be used throughout the session, and the speakers will answer questions about how to apply the learnings in the session to participants’ own intervention development projects.

Learning objectives:

  1. Describe the specific “Go-No Go criteria” used to move from one phase to the next in the ORBIT model;
  2. Identify when and how phases of the model can be combined;
  3. Describe how Phase II efficacy trials are different from Phase III trials;
  4. Apply the learnings from this session to their own intervention development projects.

Readings:

  1. Czajkowski & Hunter, 2021; Powell et al chapter 3 on “Behavioral Treatment Development” from Behavioral Clinical Trials and Powell et al 2018 (Download this bundle)
  2. NIH Guidance on Phase II vs. Phase III trials 
  3. Freedland 2020, Pilot Trials in Health-Related Behavioral Intervention Research: Problems, Solutions, and Recommdations

WORKSHOP 5: Bringing Evidence to the People: Strategies to Enable the Uptake of Evidence-Based Public Health Interventions for Population Health and Equity

Afternoon Session (13h30 to 16h30) – Falko Sniehotta, PhD (Germany)

Despite a growing body of robust evidence demonstrating the effectiveness of public health interventions in reducing risk and preventing disease, their uptake in real-world settings remains limited. This “evidence-to-practice gap” is particularly pronounced in settings with constrained resources and contributes to persistent health inequities.

Barriers to adoption extend beyond the strength of evidence. Challenges include limited transferability and generalisability of findings across contexts, insufficient attention to implementation feasibility, and a lack of structured support for local decision-makers tasked with selecting, adapting, and delivering interventions. As a result, many proven interventions fail to achieve meaningful population-level impact.

This interactive workshop will explore key barriers to the translation of public health evidence into practice, drawing on real-world examples and participant experience. It will introduce practical strategies to enhance the design, adaptation, and implementation of interventions in diverse settings. Participants will engage in structured discussions and applied exercises to identify actionable approaches for increasing the real-world impact of public health research and improving health equity.

Learning Objectives

  • By the end of the workshop, participants will be able to:
  • Identify key barriers to the uptake and implementation of evidence-based public health interventions across different contexts.
  • Critically assess the transferability and generalisability of public health evidence.
  • Develop strategies to enhance implementability, including stakeholder engagement, contextualisation, and feasibility assessment.
  • Reflect on how research design can better support real-world impact, particularly in advancing population health and reducing inequities

WORKSHOP 6: Strategies for rapid design and prototype testing of digital behavioural interventions

Afternoon Session (13h30 to 16h30) – Sam Liu, PhD (Canada)

*Participants are encouraged to bring a laptop or a tablet to this workshop.

Learning Objectives

  1. Apply behavioural science theories and user-centered design approaches to the rapid development of mobile and web-based behavioural interventions.
  2. Discuss evaluation methods (e.g., optimization trial designs) and measures used to refine interventions based on user feedback and behavioural data.
  3. Develop and prototype mobile and web-based intervention components using “no-code” software tools.
Pavillon Sherbrooke: 200 Sherbrooke Street West
Pavillon Adrien-Pinard: 100 Sherbrooke Street West